Research
Print page Print page
Switch language
Bispebjerg Hospital - a part of Copenhagen University Hospital
Published

Apolipoprotein M and risk of type 2 diabetes

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Elevated apolipoprotein A1 and HDL cholesterol associated with age-related macular degeneration: 2 population cohorts

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Treatment of Hyperthyroidism Reduces Systemic Oxidative Stress, as Measured by Markers of RNA and DNA Damage

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Male fertility before and after androgen abuse

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Identification and metabolic profiling of a novel human gut-derived LEAP2 fragment

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Genome-Wide Association Analysis of Pancreatic Beta Cell Glucose Sensitivity

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Impact of high glucose levels and glucose lowering on risk of ischaemic stroke: a Mendelian randomisation study and meta-analysis

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Elevated apolipoprotein A1 and HDL cholesterol associated with age-related macular degeneration: 2 population cohorts

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Inhibition of Cholesteryl Ester Transfer Protein Preserves High-Density Lipoprotein Cholesterol and Improves Survival in Sepsis

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

CONTEXT: Recent studies have discovered a role of apolipoprotein M (apoM) in energy metabolism, and observational analyses in humans suggest an association with type 2 diabetes. The causal relationship remains however elusive.

OBJECTIVE: To investigate whether reduced plasma apoM concentrations are causally linked to increased risk of type 2 diabetes.

DESIGN: Prospective study design analyzed by Mendelian randomization.

SETTING AND PARTICIPANTS: Two cohorts reflecting the Danish general population: the Copenhagen City Heart Study (CCHS, n = 8589) and the Copenhagen General Population Study (CGPS; n = 93 857). Observational analyses included a subset of participants from the CCHS with available plasma apoM (n = 725). Genetic analyses included the complete cohorts (n = 102 446). During a median follow-up of 16 years (CCHS) and 8 years (CGPS), 563 and 2132 participants developed type 2 diabetes.

MAIN OUTCOME MEASURES: Plasma apoM concentration, genetic variants in APOM, and type 2 diabetes.

RESULTS: First, we identified an inverse correlation between plasma apoM and risk of type 2 diabetes in a subset of participants from the CCHS (hazard ratio between highest vs lowest quartile (reference) = 0.32; 95% confidence interval = 0.1-1.01; P for trend = .02). Second, genotyping of specific single nucleotide polymorphisms in APOM further revealed a 10.8% (P = 6.2 × 10-5) reduced plasma apoM concentration in participants with variant rs1266078. Third, a meta-analysis including data from 599 451 individuals showed no association between rs1266078 and risk of type 2 diabetes.

CONCLUSIONS: The present study does not appear to support a causal association between plasma apoM and risk of type 2 diabetes.

Original languageEnglish
Article numberdgaa433
JournalThe Journal of clinical endocrinology and metabolism
Volume105
Issue number9
Pages (from-to)3046-3057
Number of pages12
ISSN0021-972X
DOIs
Publication statusPublished - 1 Sep 2020

    Research areas

  • apolipoproteins, type 2 diabetes, genetics, mendelian randomization

ID: 60693244